| Name |
Dasatinib, Free Base
|
| Supplier |
Biorbyt
|
| Catalog |
orb61015
|
| Prices |
$289.00, $340.00, $349.00, $536.00, $731.00, $1,530.00
|
| Sizes |
500 mg, 1 g, 2 g, 5 g, 10 g, 25 g
|
| Cas Number |
[302962-49-8]
|
| Pubchem |
3062316
|
| Chemical Name |
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
|
| Formula |
C22H26ClN7O2S
|
| Molecular Weight |
488.01 g/mol
|
| Purity |
>99% pure
|
| Description |
Dasatinib (BMS-354825, Sprycel) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of ＜1 nM, 0.5 nM and 79 nM, respectively. Dasatinib has entered in a phase II clinical trial in the treatment of hemangiopericytoma and gastrointestinal stromal tumor.
|
| Supplier Page |
Shop
|
Dasatinib (BMS-354825) Chemical Structure